drugset / Trial / NCT04224116
Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery
RandomizedParallel-groupTriple-blindPrevention
Summary
Bleeding after thoracic surgery is a major cause of perioperative hemodynamic instability and transfusion requirement, which can lead to a rise of morbidity, mortality and costs. The objective of this study is to evaluate the efficiency of tranexamic acid (TA) in the prevention of perioperative bleeding in thoracic hemorrhagic surgery.
Timeline
- Start
- 2014-01-01
- Primary completion
- 2019-10-02
- Completion
- 2019-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 2 mg/kg | — |